Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedFeb 8, 2017Finasteride TabletsFailed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.Hetero Drugs Ltd. - Unit 1 · D-0453-2017Class IITerminatedFeb 8, 2017Flucanozole TabletsFailed Dissolution Specifications; 18 month stability time pointDr. Reddy's Laboratories, Inc. · D-0452-2017Class IITerminatedFeb 8, 2017Flucanozole TabletsFailed Dissolution Specifications; 18 month stability time pointDr. Reddy's Laboratories, Inc. · D-0451-2017Class IITerminatedFeb 8, 2017Flucanozole TabletsFailed Dissolution Specifications; 18 month stability time pointDr. Reddy's Laboratories, Inc. · D-0450-2017Class IITerminatedFeb 8, 2017Flucanozole TabletsFailed Dissolution Specifications; 18 month stability time pointDr. Reddy's Laboratories, Inc. · D-0449-2017Class IIITerminatedFeb 1, 2017Azelastine Hydrochloride Nasal SolutionDefective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..Roxane Laboratories, Inc. · D-0448-2017Class IITerminatedFeb 1, 2017MesalaminePresence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.Cambrex Charles City Inc · D-0447-2017Class IIITerminatedFeb 1, 2017buPROPion Hydrochloride Extended-release TabletsFailed Dissolution Specifications; 18 month stability time pointSun Pharmaceutical Industries, Inc. · D-0446-2017Class IIITerminatedFeb 1, 2017buPROPion Hydrochloride Extended-release TabletsFailed Dissolution Specifications; 18 month stability time pointSun Pharmaceutical Industries, Inc. · D-0445-2017Class IITerminatedFeb 1, 2017Temozolomide CapsulesFailed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Mylan LLC. · D-0444-2017Class IITerminatedFeb 1, 2017Temozolomide CapsulesFailed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Mylan LLC. · D-0443-2017Class IITerminatedFeb 1, 2017Temozolomide CapsulesFailed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Mylan LLC. · D-0442-2017Class IITerminatedFeb 1, 2017Temozolomide CapsulesFailed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Mylan LLC. · D-0441-2017Class IITerminatedFeb 1, 2017Amoxicillin for Oral Suspension USPSubpotency: due to a low, out of specification test result for assay during stability testing.Teva Pharmaceuticals USA · D-0440-2017Class IIITerminatedFeb 1, 2017Albuterol Sulfate Inhalation SolutionFailed Impurities/Degradation Specifications: Product is out of specification for a known degradant.Actavis Inc · D-0439-2017Class IIITerminatedFeb 1, 2017DEXAMETHASONE ELIXIRFailed Impurities/ Degradation SpecificationsVintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals · D-0438-2017Class IITerminatedFeb 1, 2017Furosemide Tablets USPFailed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.Roxane Laboratories, Inc. · D-0437-2017Class IIITerminatedJan 25, 2017HCG (Chorionic Gonadotropin Lyopholized) IISubpotent Drug: due to failed potency results of 74% (spec. 80-125%).Town and Country Compounding and Consultation Services, LLC · D-0436-2017Class IIITerminatedJan 25, 2017Donepezil Hydrochloride TabletsSubpotent Drug: out of specification results for assay test.Sandoz Inc · D-0435-2017Class IITerminatedJan 25, 2017Clindamycin Phosphate and Benzoyl Peroxide GelMicrobial Contamination of Non-Sterile Product; small number of tubes may include the presence of mold on the capL. Perrigo Company · D-0434-2017Class IIITerminatedJan 25, 2017Novacort Gel Sample PacketsSubpotent Drug: Out of specification result for pramoxine hydrochlorideNovum Pharma, LLC · D-0433-2017Class IIITerminatedJan 25, 2017PentasaPresence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsulesShire PLC · D-0432-2017Class IIITerminatedJan 25, 2017Risedronate Sodium Delayed-release TabletsFailed Dissolution SpecificationsTeva Pharmaceuticals USA · D-0431-2017Class IITerminatedJan 18, 2017DaytranaDefective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.Noven Pharmaceuticals, Inc. · D-0430-2017Class IITerminatedJan 18, 2017DaytranaDefective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.Noven Pharmaceuticals, Inc. · D-0429-2017Class IITerminatedJan 18, 2017DaytranaDefective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.Noven Pharmaceuticals, Inc. · D-0428-2017Class IIITerminatedJan 18, 2017HCG-Vitamin B12 5000 IU-8 mg in 10 mL vialLabeling; Error on Declared Strength; product description incorrectly states HCG 7500 units instead of 5000 units. The primary panel is correctPharm D Solutions, LLC · D-0427-2017Class IIITerminatedJan 18, 2017Testosterone Cypionate 200 mg/mL in Sesame OilIncorrect/Undeclared Excipient; product description section of testosterone cypionate incorrectly states "in grapeseed oil" instead of "in sesame oil" . The primary...Pharm D Solutions, LLC · D-0426-2017Class IITerminatedJan 18, 201710% Premasol sulfite-freeDiscoloration: there were customer reports of yellow discolored solution. The yellow coloration is the result of oxidation of the amino acid tryptophan due to a damaged...Baxter Healthcare Corporation · D-0425-2017Class IIITerminatedJan 18, 2017CytotecFailed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 monthsPfizer Inc. · D-0424-2017Class IITerminatedJan 11, 2017Testosterone Cypionate in Sesame Oil InjectableLack of Assurance of SterilityWells Pharmacy Network LLC · D-0423-2017Class IITerminatedJan 11, 2017Testosterone Cypionate in Grapeseed Oil InjectableLack of Assurance of SterilityWells Pharmacy Network LLC · D-0422-2017Class IITerminatedJan 11, 2017Vitamin D3 in Sesame Oil Injectable 50Lack of Assurance of SterilityWells Pharmacy Network LLC · D-0421-2017Class IITerminatedJan 11, 2017Vitamin D3 in Sesame Oil Injectable 100Lack of Assurance of SterilityWells Pharmacy Network LLC · D-0420-2017Class IITerminatedJan 11, 2017Tri-Test 200Lack of Assurance of SterilityWells Pharmacy Network LLC · D-0419-2017Class IITerminatedJan 11, 2017Trimix Injectable 30 mg/3 mg/60 mcg/mLLack of Assurance of SterilityWells Pharmacy Network LLC · D-0418-2017Class IITerminatedJan 11, 2017Trimix Injectable 30 mg/3 mg/100 mcg/mLLack of Assurance of SterilityWells Pharmacy Network LLC · D-0417-2017Class IITerminatedJan 11, 2017Trimix Injectable 30 mg/1 mg/25 mcg/mLLack of Assurance of SterilityWells Pharmacy Network LLC · D-0416-2017Class IITerminatedJan 11, 2017Trimix Injectable 30 mg/1 mg/10 mcg/mL a) 2 mL and b) 5 mL and c) 10 mL vialsLack of Assurance of SterilityWells Pharmacy Network LLC · D-0415-2017Class IITerminatedJan 11, 2017Trimix Injectable 17.65 mg/0.59 mg/5.9 mcg/mL a) 2 mLLack of Assurance of SterilityWells Pharmacy Network LLC · D-0414-2017